Last updated on November 2017

Non-Idiopathic Constipation


Brief description of study

Non-Idiopathic Constipation

Detailed Study Description

The purpose of the study is to evaluate multiple doses of SUPREP-currently approved as a bowel prep kit being tested now as BLI801 laxative for safety and efficacy versus placebo in adults experiencing opioid-induced constipation. You have 3 in 4 chance to receive active treatment

Dulcolax is provided if needed.

Clinical Study Identifier: TX10095

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Carrie Covert

MediSphere Medical Research Center, LLC
Evansville, IN USA
  Connect »